Microsoft Word 10.0.2627;UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
OMB APPROVAL
OMB Number 3235-0058
Expires March 31, 2006
Estimated average burden
hours per response...2.50
SEC FILE NUMBER
01-28911
CUSIP NUMBER
635904 20 4
Check One:
[X]Form 10-K [ ]Form 20-F [ ]Form 11-K [ ]Form 10-Q [ ]Form N-SAR
For Period Ended: December 31, 2005
[ ]Transition Report on Form 10-K
[ ]Transition Report on Form 20-F
[ ]Transition Report on Form 11-K
[ ]Transition Report on Form 10-Q
[ ]Transition Report on Form N-SAR
For the Transition Period Ended: _______________________________
--------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
--------------------------------------------------------------------------------
Full Name of Registrant NATIONAL HEALTHCARE TECHNOLOGY, INC.
--------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
1660 Union Street, Suite 200
--------------------------------------------------------------------------------
City, State and Zip Code
San Diego, California 92101
--------------------------------------------------------------------------------
-1-
--------------------------------------------------------------------------------
PART II -- Rules 12b-25(b) and (c)
--------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to 12b-25(b) [Paragraph 23,047], the
following should be completed.
(Check box if appropriate.) [X]
(a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
(b) The subject annual report, semiannual report, transition report on Form
10-K, Form 20-F, 11-K, Form N-SAR, or portion thereof, will be filed on or
before the fifteenth calendar day following the prescribed due date or the
subject quarterly report of transition report on Form 10-Q, or portion
thereof, will be filed on or before the fifth calendar day following the
prescribed due date; and
(c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
--------------------------------------------------------------------------------
PART III -- NARRATIVE
--------------------------------------------------------------------------------
State below in reasonable detail the reasons why the Form 10-K, 20-F, 11-K,
10-Q, N-SAR, or the transition report, or portion thereof, could not be filed
within the prescribed time period.
The 2005 audit will be completed around April 7, 2006.
--------------------------------------------------------------------------------
PART IV -- OTHER INFORMATION
--------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification.
Dave Neville (805) 640-6468
--------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
--------------------------------------------------------------------------------
(2) Have all other periodic reports under Section 13 or 15(d) of the Securities
Exchange Act of 1934 ("Exchange Act") or Section 30 of the Investment Company
Act of 1940 during the preceding twelve months (or for such shorter period that
the registrant was required to filer such reports) been filed?
[X] YES [ ] NO
If the answer is no, identify reports.
--------------------------------------------------------------------------------
-2-
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report, or portion thereof?
[ ] YES [X] NO
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
-------------------------------------------------------------------------------
NATIONAL HEALTHCARE TECHNOLOGY, INC.
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date: March 31, 2005 By /s/ Ross Lyndon James
--------------------------------
Ross Lyndon James
CEO
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
-3-